HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$28.75
Day range
$27.04 - $28.37
Year range
$6.40 - $30.27
Market cap
2.42B USD
Avg Volume
801.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 69.16M | 52.11% |
Net income | -65.65M | -48.57% |
Net profit margin | — | — |
Earnings per share | -0.81 | -3.85% |
EBITDA | -68.77M | -52.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 453.55M | 90.40% |
Total assets | 522.28M | 80.94% |
Total liabilities | 44.22M | -5.32% |
Total equity | 478.06M | — |
Shares outstanding | 87.38M | — |
Price to book | 5.24 | — |
Return on assets | -50.31% | — |
Return on capital | -55.47% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -65.65M | -48.57% |
Cash from operations | -78.54M | -67.43% |
Cash from investing | -179.84M | -764.54% |
Cash from financing | 408.39M | 1,317.28% |
Net change in cash | 150.01M | 1,572.58% |
Free cash flow | -80.21M | -154.05% |
About
Founded
2017
Headquarters
Website
Employees
143